Loading market data...

DeepSeek Invests $21 Million in Unitree Robotics' Shanghai IPO

DeepSeek Invests $21 Million in Unitree Robotics' Shanghai IPO

DeepSeek has committed $21 million to Unitree Robotics' initial public offering on the Shanghai Stock Exchange, according to a filing. The investment underscores the growing convergence of artificial intelligence and robotics, two sectors that have drawn increasing attention from both tech firms and investors.

The investment details

The $21 million stake comes as Unitree, a Chinese robotics company known for its quadruped robots, pushes ahead with its Shanghai IPO. DeepSeek, an AI research lab that made waves with its large language models, is buying into the offering as a cornerstone investor. The exact number of shares and the pricing terms were not disclosed in the filing.

Unitree's IPO has been closely watched because it represents one of the first major public listings by a Chinese robotics firm focused on consumer and industrial legged robots. The company's products include the Unitree Go1 and B2 series, which are used in inspection, education, and entertainment.

Who is Unitree Robotics

Founded in 2016, Unitree designs and manufactures legged robots that can walk, run, and climb stairs. The company competes with Boston Dynamics but at a lower price point, aiming to make advanced robotics more accessible. Its robots are used by universities, research labs, and some industrial clients. The Shanghai IPO is expected to raise capital for expansion and R&D.

Why the investment matters

DeepSeek's move signals a bet on the integration of AI brains with robotic bodies. While DeepSeek is best known for its large language models, the company appears to be looking beyond pure software toward embodied AI — systems that can perceive and act in the physical world. The investment also comes at a time when Chinese tech firms are racing to develop humanoid and general-purpose robots.

For Unitree, having a high-profile AI investor like DeepSeek could boost confidence among other potential backers. The IPO is expected to price in the coming weeks, and the final allocation will depend on demand from institutional and retail investors.

Neither company has commented publicly beyond the regulatory filing. The deal still requires approval from Chinese securities regulators.